Table 2. Effect size of several cognitive test and risk of cognitive impairment in men treated with androgen deprivation therapy or controls.
| Risk factor | McGinty et al (2014) [32]a | Sun et al (2018) [33]b |
|---|---|---|
| Attention/working memory | −0.07 (−0.67–0.53) | |
| Executive function | −0.06 (−0.80–0.67) | |
| Language | −0.19 (−0.82–0.43) | |
| Verbal memory | −0.05 (−0.47–0.37) | |
| Visual memory | 0.22 (−0.19–0.63) | |
| Visuomotor ability | −0.67 (−1.17–−0.17) | |
| Visuospatial ability | 0.06 (−0.55–0.56) | |
| Any cognitive impairment prospective studiesc | 1.57 (0.50–4.92) | |
| Any cognitive impairment prospective studiesd | NA | 1.75 (0.49–6.25) |
| Any cognitive impairment retrospective studiese | NA | 1.28 (0.93–1.76) |
NA: not available.
aEffect size (95% confidence interval [CI]). bOdds ratio (95% CI). cScoring 1.5 or more standard deviations below published norms on 2 or more tests; dScoring 2.0 or more standard deviations below published norms on at least 1 test; eDefined using International Classification of Diseases-9 diagnostic or procedure codes or other system based identification scheme.